From Liston Street Pulse:
After having fallen very badly from over the patent cliff, Merck (NYSE: MRK) took up an ambitious cost cutting program in which it was to lay off 8,500 workers and cut $2.5 billion in costs. It now appears that cost restructuring is not the end all of coming out of […]
The post Merck Sells Saphris And Also Cuts 150 Jobs appeared first on Liston Street Pulse.
Created by Stock Researching | Dec 13, 2016
Created by Stock Researching | Dec 04, 2016
Created by Stock Researching | Dec 02, 2016
Created by Stock Researching | Nov 19, 2016
Created by Stock Researching | Nov 10, 2016
Created by Stock Researching | Oct 05, 2015